These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 13258921)

  • 1. Preliminary experiences with a 50 gram converging beam radium unit.
    QUICK D; RICHMOND JD
    Am J Roentgenol Radium Ther Nucl Med; 1955 Oct; 74(4):635-50. PubMed ID: 13258921
    [No Abstract]   [Full Text] [Related]  

  • 2. The mesothorium-radium beam unit.
    BEHOUNEK F; KLUMPAR J
    Acta Radiol (Stockh); 1951; 35(5-6):375-86. PubMed ID: 14868541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some improvements to our technic of cross beam centering by moulded apparatus].
    AMALRIC R; CLEMENT R
    J Radiol Electrol Arch Electr Medicale; 1953; 34(5-6):406-8. PubMed ID: 13097507
    [No Abstract]   [Full Text] [Related]  

  • 4. Convergent beam roentgen tube.
    BACHMAN CH; DAVIS HW; GELORMINI OJ
    Am J Roentgenol Radium Ther Nucl Med; 1955 Jan; 73(1):103-9. PubMed ID: 13218205
    [No Abstract]   [Full Text] [Related]  

  • 5. Radium beam therapy.
    WOOD CA
    J Fac Radiol; 1951 Oct; 3(2):79-94. PubMed ID: 24541740
    [No Abstract]   [Full Text] [Related]  

  • 6. Radium beam therapy at the Western Infirmary of Glasgow, 1938-48.
    CHARTERIS AA
    J Fac Radiol; 1951 Oct; 3(2):95-110. PubMed ID: 24541741
    [No Abstract]   [Full Text] [Related]  

  • 7. Beam flatteners for a teletherapy unit.
    CHAUNDY CJ
    J Can Assoc Radiol; 1961 Sep; 12():82-5. PubMed ID: 13878496
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II Study of Propylene Glycol-Free Melphalan Combined with Carmustine, Etoposide, and Cytarabine for Myeloablative Conditioning in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
    Cashen AF; Fletcher T; Ceriotti C; Gao F; Ghobadi A; Vij R; Stockerl-Goldstein K; DiPersio J; Abboud C
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2155-2158. PubMed ID: 27575541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving beam irradiation in orthovoltage radiotherapy.
    MAHFOUZ MM
    J Egypt Med Assoc; 1962; 45():254-81. PubMed ID: 14468433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Centering of the beam in pendulum cyclotherapy and in convergent pendulum cyclotherapy].
    DE VULPIAN P
    J Radiol Electrol Arch Electr Medicale; 1958 May; 39(4):322. PubMed ID: 13550314
    [No Abstract]   [Full Text] [Related]  

  • 11. The technique and results of treatment of cancer of the tongue with a 10 gram radium beam unit.
    WOOD CA
    Am J Roentgenol Radium Ther; 1950 May; 63(5):727-38. PubMed ID: 15410934
    [No Abstract]   [Full Text] [Related]  

  • 12. The development of a beam-walking test and its use in measuring development of balance in children.
    SEASHORE HG
    Res Q; 1947 Dec; 18(4):246-59. PubMed ID: 18898569
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2).
    Glossmann JP; Josting A; Pfistner B; Paulus U; Engert A;
    Ann Hematol; 2002 Aug; 81(8):424-9. PubMed ID: 12223998
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption measurements for broad beams of 1- and 2-million-volt X-rays.
    SINGER G; BRAESTRUP CB; WYCKOFF HO
    J Res Natl Bur Stand (1934); 1946 Aug; 37(2):147-50. PubMed ID: 20999090
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of changed spacer tubes of the convergent beam irradiator].
    FETZER H
    Strahlentherapie; 1954 Oct; 95(2):312-5. PubMed ID: 13226075
    [No Abstract]   [Full Text] [Related]  

  • 16. Cobalt 60 beam therapy.
    EVANS AM; MOFFAT RG; NASH RD; BATHO HF; MIBUS SA
    J Fac Radiol; 1954 Apr; 5(4):248-60. PubMed ID: 24543588
    [No Abstract]   [Full Text] [Related]  

  • 17. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.
    Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G;
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH; Chen YA; Corringham S; Bashey A; Holman P; Ball ED; Carrier E
    Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Smith RJ; Sweetenham JW
    Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
    Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.